speb/financial-data huggingface dataset:
Financial ratios for SRF.NS — quarterly report dated 2024-12-31
Total revenue: 397096398.18160623
Gross profit: 186627812.09931225
Operating income: 53564518.009091966
Net income: 31598088.355286162
Capital expenditures: 0
Depreciation & amortization: 22643664.762792863
Owner earnings: 54241753.11807902
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.972374402611027
P/E ratio: 60.908496820518856
Shares outstanding: 296406025
Market cap (USD): 7698368256.489684
Effective tax rate (%): 26.476810414971524
Interest coverage ratio: 4.774337662337662
COGS to revenue (%): 53.001887462610334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SRF.NS — quarterly report dated 2025-03-31
Total revenue: 492771802.66541964
Gross profit: 231789805.9387421
Operating income: 94386252.04582651
Net income: 61498714.051905535
Capital expenditures: 0
Depreciation & amortization: 22813888.239420153
Net tangible assets: 1462912087.912088
Owner earnings: 84312602.29132569
Return on net tangible assets (%): 5.763340325641794
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.19185435873498
P/E ratio: 41.198713640165685
Shares outstanding: 296406025
Book value: 1476057984.568623
P/B ratio: 6.866038965815703
Market cap (USD): 10134671637.851559
Debt to equity: 0.37430343254502535
Current ratio: 1.128845123233633
Quick ratio: 0.6962483862591231
Effective tax rate (%): 25.630513458493553
Interest coverage ratio: 9.032106499608458
COGS to revenue (%): 52.9620394906967
Buyback yield (%): 0
Retained earnings: 1272061024.0823007
Inventory turnover: 0.9503910224481369
Receivables turnover: 1.942958155485697
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.006327822763916
Revenue growth (%): 24.09374774536677
Rule of 40 score: 24.09374774536677
Financial ratios for SRF.NS — annual report dated 2025-03-31
Total revenue: 1678530512.0411503
Gross profit: 766442599.9532382
Operating income: 242574234.2763619
Net income: 146221650.6897358
Capital expenditures: 142886368.95019874
Operating cash flow: 290798456.8622866
Depreciation & amortization: 90191723.17044657
Net tangible assets: 1462912087.912088
Owner earnings: 93527004.90998363
Return on net tangible assets (%): 6.393207471781041
Capex to operating income (%): 58.904182208985155
Buffett classification: The Good
Stock price: 34.19185435873498
P/E ratio: 69.31033530291677
Shares outstanding: 296406025
Book value: 1476057984.568623
P/B ratio: 6.866038965815703
Market cap (USD): 10134671637.851559
Debt to equity: 0.37430343254502535
Current ratio: 1.128845123233633
Quick ratio: 0.6962483862591231
Effective tax rate (%): 26.58449257498386
Interest coverage ratio: 5.97718565461616
COGS to revenue (%): 54.33847675362075
SG&A to revenue (%): 5.541243126725936
Free cash flow (dilution-adjusted): 145848725.74234277
Buyback yield (%): 0
Retained earnings: 1272061024.0823007
Inventory turnover: 3.3214557870045165
Receivables turnover: 6.61830593788316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.866345593993744
FCF margin (%): 8.689072060119166
Revenue growth (%): 8.418950221420435
Rule of 40 score: 17.1080222815396
Financial ratios for SRF.NS — quarterly report dated 2025-06-30
Total revenue: 437465480.9267494
Gross profit: 213887198.68944538
Operating income: 72304001.87222093
Net income: 50587409.31429909
Capital expenditures: 0
Depreciation & amortization: 23781886.262578987
Owner earnings: 74369295.57687807
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 37.81757547390592
P/E ratio: 78.01384081840193
Shares outstanding: 296406025
Market cap (USD): 11209357221.357944
Effective tax rate (%): 24.920982251398012
Interest coverage ratio: 7.733541927409262
COGS to revenue (%): 51.107639799068096
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -11.223515923499768
Rule of 40 score: -11.223515923499768
Financial ratios for SRF.NS — quarterly report dated 2025-12-31
Total revenue: 402305892.83725077
Gross profit: 197825554.19405147
Operating income: 67202851.73220453
Net income: 48196502.17221789
Capital expenditures: 0
Depreciation & amortization: 24160632.72808288
Owner earnings: 72357134.90030077
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 34.19104377854517
P/E ratio: 52.81631056789516
Shares outstanding: 296406025
Market cap (USD): 10134431376.999556
Effective tax rate (%): 4.208825027121571
Interest coverage ratio: 9.210381679389313
COGS to revenue (%): 50.82708016059809
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.037111411628354
Rule of 40 score: -8.037111411628354
Financial ratios for TIA.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.016891891891891893
Shares outstanding: 39909832
Market cap (USD): 674152.5675675676
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TIA.L — annual report dated 2022-12-31
Total revenue: 17425301.204819277
Gross profit: 6090361.445783133
Operating income: 690361.4457831326
Net income: -707228.9156626506
Capital expenditures: 250602.40963855424
Operating cash flow: 1777108.43373494
Depreciation & amortization: 1659036.1445783132
Net tangible assets: -1312048.1927710844
Owner earnings: 701204.8192771084
Capex to operating income (%): 36.30017452006981
Buffett classification: The Good
Stock price: 0.008192771084337351
Shares outstanding: 39909832
Book value: 7196385.542168675
P/B ratio: 0.045435603147497075
Market cap (USD): 326972.1175903615
Debt to equity: 0.7714716223003515
Current ratio: 0.8480749219562955
Quick ratio: 0.8480749219562955
Interest coverage ratio: 0.24550128534704369
COGS to revenue (%): 65.04874507363617
SG&A to revenue (%): 7.453502039687479
Free cash flow (dilution-adjusted): 1526506.0240963856
Buyback yield (%): 0
Retained earnings: -69186746.98795182
Receivables turnover: 5.787515006002401
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.397513187641296
FCF margin (%): 8.760284864827492
Rule of 40 score: 8.760284864827492
Financial ratios for TIA.L — annual report dated 2023-12-31
Total revenue: 28369620.253164556
Gross profit: 8417721.51898734
Operating income: -1539240.5063291139
Net income: -1944303.7974683542
Capital expenditures: 94936.70886075949
Operating cash flow: 832911.3924050633
Depreciation & amortization: 3163291.139240506
Net tangible assets: -650632.911392405
Owner earnings: 1124050.6329113925
Buffett classification: The Gruesome
Stock price: 0.007848101265822784
Shares outstanding: 39909832
Book value: 8332911.392405061
P/B ratio: 0.037587871547926484
Market cap (USD): 313216.4030379746
Debt to equity: 0.7321889715934985
Current ratio: 0.9943651389932381
Quick ratio: 0.9943651389932381
Interest coverage ratio: -1.8480243161094225
COGS to revenue (%): 70.32839550240942
SG&A to revenue (%): 35.097269320007136
Free cash flow (dilution-adjusted): 724050.6329113924
Buyback yield (%): 0
Retained earnings: -74634177.21518987
Receivables turnover: 5.979722518676628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.624726955002185
FCF margin (%): 2.5522041763341066
Revenue growth (%): 62.80705808011189
Rule of 40 score: 65.35926225644599
Financial ratios for TIA.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -946250
Buffett classification: The Gruesome
Stock price: 0.004124999999999999
Shares outstanding: 39909832
Book value: 5075000
P/B ratio: 0.032439026009852205
Market cap (USD): 164628.05699999997
Debt to equity: 1.2342364532019705
Current ratio: 0.996915365336418
Quick ratio: 0.996915365336418
Buyback yield (%): 0
Retained earnings: -77686250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TIA.L — annual report dated 2024-12-31
Total revenue: 26052500
Gross profit: 7515000
Operating income: -1550000
Net income: -3992500
Capital expenditures: 35000
Operating cash flow: 2361250
Depreciation & amortization: 3335000
Net tangible assets: -946250
Owner earnings: -692500
Buffett classification: The Gruesome
Stock price: 0.004124999999999999
Shares outstanding: 39909832
Book value: 5075000
P/B ratio: 0.032439026009852205
Market cap (USD): 164628.05699999997
Debt to equity: 1.2342364532019705
Current ratio: 0.996915365336418
Quick ratio: 0.996915365336418
Interest coverage ratio: -2.6609442060085837
COGS to revenue (%): 71.15439976969581
SG&A to revenue (%): 3.8815852605316192
Free cash flow (dilution-adjusted): 1603750
Buyback yield (%): 0
Retained earnings: -77686250
Receivables turnover: 7.01278600269179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.629369092108156
FCF margin (%): 6.155839170904904
Revenue growth (%): -8.167611101195785
Rule of 40 score: -2.011771930290881
Financial ratios for TIA.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -1015068.493150685
Buffett classification: The Gruesome
Stock price: 0.008767123287671234
Shares outstanding: 39909832
Book value: 4847945.205479454
P/B ratio: 0.07217375665442213
Market cap (USD): 349894.41753424663
Debt to equity: 1.2367900536874816
Current ratio: 0.9160777385159012
Quick ratio: 0.9160777385159012
Buyback yield (%): 0
Retained earnings: -86346575.34246576
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TOPS — annual report dated 2021-12-31
Capital expenditures: 131264772.72727273
Buffett classification: The Gruesome
Stock price: 201.6
Shares outstanding: 5541670
Market cap (USD): 1117200672
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TOPS — annual report dated 2022-12-31
Total revenue: 85804255.31914894
Gross profit: 38564893.61702128
Operating income: 34618085.10638298
Net income: 20157446.80851064
Capital expenditures: 154212765.9574468
Operating cash flow: 35552127.65957447
Depreciation & amortization: 23259574.468085106
Net tangible assets: 209598936.17021278
Owner earnings: -110795744.68085107
Return on net tangible assets (%): -52.86083350674794
Capex to operating income (%): 445.4687932147137
Buffett classification: The Gruesome
Stock price: 15.24
P/E ratio: 4.189769250158328
Shares outstanding: 5541670
Book value: 209598936.17021275
P/B ratio: 0.402936447785284
Market cap (USD): 84455050.8
Debt to equity: 1.3243783720682358
Current ratio: 0.7101597642314255
Quick ratio: 0.6783310066697689
Interest coverage ratio: 2.7786696268465545
COGS to revenue (%): 55.05480063479469
SG&A to revenue (%): 2.0048105534616147
Free cash flow (dilution-adjusted): -194977659.5744681
Buyback yield (%): 20.413729396412716
Retained earnings: -338091489.36170214
Inventory turnover: 43.27972709551658
Receivables turnover: 10082
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.444715421114523
FCF margin (%): -227.23541955961116
Rule of 40 score: -227.23541955961116
Financial ratios for TOPS — annual report dated 2023-12-31
Total revenue: 92165555.55555555
Gross profit: 41804444.44444444
Operating income: 31918888.888888888
Net income: 6740000
Capital expenditures: 0
Operating cash flow: 32147777.777777776
Depreciation & amortization: 26201111.111111112
Net tangible assets: 203755555.55555555
Owner earnings: 32941111.111111112
Return on net tangible assets (%): 16.166975678918092
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.62
P/E ratio: 12.842861335311571
Shares outstanding: 5541670
Book value: 203755555.55555558
P/B ratio: 0.4248271177881993
Market cap (USD): 86560885.39999999
Debt to equity: 1.4223743047224342
Current ratio: 0.9362128976119114
Quick ratio: 0.9140964903799671
Interest coverage ratio: 1.325107246644218
COGS to revenue (%): 54.64200894525552
SG&A to revenue (%): 8.073635607421428
Free cash flow (dilution-adjusted): 32147777.777777776
Buyback yield (%): 33.75016823065496
Retained earnings: -346377777.7777778
Inventory turnover: 49.53551912568306
Receivables turnover: 261.6687697160883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.875498124777116
FCF margin (%): 34.880468721744684
Revenue growth (%): 7.413735149551444
Rule of 40 score: 42.294203871296126
Financial ratios for TOPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 150437500
Buffett classification: The Gruesome
Stock price: 6.03
Shares outstanding: 5541670
Book value: 150437500
P/B ratio: 0.22212726281678438
Market cap (USD): 33416270.1
Debt to equity: 1.8391843235009002
Current ratio: 0.7061215882388383
Quick ratio: 0.6765078026149304
Buyback yield (%): 0
Retained earnings: -319485416.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TOPS — annual report dated 2024-12-31
Total revenue: 89715625
Gross profit: 39245833.333333336
Operating income: 29066666.666666668
Net income: 5243750
Capital expenditures: 0
Operating cash flow: 18043750
Depreciation & amortization: 24110416.666666668
Net tangible assets: 150437500
Owner earnings: 29354166.666666668
Return on net tangible assets (%): 19.512532890181415
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.03
P/E ratio: 6.372590245530394
Shares outstanding: 5541670
Book value: 150437500
P/B ratio: 0.22212726281678438
Market cap (USD): 33416270.1
Debt to equity: 1.8391843235009002
Current ratio: 0.7061215882388383
Quick ratio: 0.6765078026149304
Interest coverage ratio: 1.2759614065572271
COGS to revenue (%): 56.25529740963926
SG&A to revenue (%): 8.715037096380925
Free cash flow (dilution-adjusted): 18043750
Buyback yield (%): 136.89688644614267
Retained earnings: -319485416.6666667
Inventory turnover: 49.28891149542218
Receivables turnover: 77.38274932614556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.162622119318852
FCF margin (%): 20.112159949841512
Revenue growth (%): -2.6581845471313663
Rule of 40 score: 17.453975402710146
Financial ratios for UCAL.NS — annual report dated 2022-03-31
Total revenue: 102096703.1517869
Gross profit: 43797388.89621522
Operating income: 4150863.7742318343
Net income: 4600580.245285507
Capital expenditures: 4086904.9188975343
Operating cash flow: 10621455.88817091
Depreciation & amortization: 5444837.135698273
Net tangible assets: 47788474.21864697
Owner earnings: 5958512.462086247
Return on net tangible assets (%): 12.468513714884931
Capex to operating income (%): 98.4591434743932
Buffett classification: The Gruesome
Stock price: 1.4338652248450483
P/E ratio: 6.892164942728071
Shares outstanding: 22113625
Book value: 51632282.73770275
P/B ratio: 0.6141110987450183
Market cap (USD): 31707957.882764082
Debt to equity: 0.6266585037683168
Current ratio: 0.8104498962465626
Quick ratio: 0.4274490209395923
Effective tax rate (%): 10.614725536014431
Interest coverage ratio: 1.4130766606209708
COGS to revenue (%): 57.10205369599275
SG&A to revenue (%): 2.582216232951903
Free cash flow (dilution-adjusted): 6451364.895160227
Buyback yield (%): 0
Retained earnings: 23444586.575234078
Inventory turnover: 4.161179405120482
Receivables turnover: 7.985016992156277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.288463797580032
FCF margin (%): 6.318876806011062
Rule of 40 score: 6.318876806011062
Financial ratios for UCAL.NS — annual report dated 2023-03-31
Total revenue: 99831278.92813642
Gross profit: 41009049.93909866
Operating income: 2364835.5663824608
Net income: 103836.78440925702
Capital expenditures: 4259695.493300853
Operating cash flow: 9522289.890377589
Depreciation & amortization: 4632070.645554203
Net tangible assets: 44890913.52009744
Owner earnings: 476211.93666260596
Return on net tangible assets (%): 1.0608203293733556
Capex to operating income (%): 180.1264981741204
Buffett classification: The Gruesome
Stock price: 1.3024360535931792
P/E ratio: 277.37359780058654
Shares outstanding: 22113625
Book value: 47909683.313032895
P/B ratio: 0.601164117229816
Market cap (USD): 28801582.475639466
Debt to equity: 0.5217000115676446
Current ratio: 0.7223641961343995
Quick ratio: 0.4187578725698023
Effective tax rate (%): 86.74410287509136
Interest coverage ratio: 0.9152591112012031
COGS to revenue (%): 58.921642215343105
SG&A to revenue (%): 2.4477230035377597
Free cash flow (dilution-adjusted): 5249926.918392205
Buyback yield (%): 0
Retained earnings: 21296467.72228989
Inventory turnover: 4.93618323950169
Receivables turnover: 6.894918328323755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.219622124170379
FCF margin (%): 5.258799621480724
Revenue growth (%): -2.2189004676110553
Rule of 40 score: 3.039899153869669
Financial ratios for UCAL.NS — annual report dated 2024-03-31
Total revenue: 86205132.50989327
Gross profit: 37656757.404964626
Operating income: 641527.7611224367
Net income: -3029032.258064516
Capital expenditures: 10237258.664108407
Operating cash flow: 4670631.970260223
Depreciation & amortization: 4003369.708598153
Net tangible assets: 42013274.97301835
Owner earnings: -9262921.213574769
Return on net tangible assets (%): -22.0476057139644
Capex to operating income (%): 1595.7623791988335
Buffett classification: The Gruesome
Stock price: 1.7334452975047985
Shares outstanding: 22113625
Book value: 44510888.59575489
P/B ratio: 0.8611995957926222
Market cap (USD): 38332759.267034546
Debt to equity: 0.72177507022943
Current ratio: 0.8227400668349472
Quick ratio: 0.48277822562656464
Interest coverage ratio: 0.2279756755489834
COGS to revenue (%): 56.31726753549974
SG&A to revenue (%): 2.4057659815214163
Free cash flow (dilution-adjusted): -5933577.167526082
Buyback yield (%): 0
Retained earnings: 17388116.081064876
Inventory turnover: 4.118320424318997
Receivables turnover: 6.090266446393019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0444265396052157
FCF margin (%): -6.883090362218421
Revenue growth (%): -13.64917545336862
Rule of 40 score: -20.532265815587042
Financial ratios for UCAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 41892606.306736745
Buffett classification: The Gruesome
Stock price: 2.308528428093646
Shares outstanding: 22113625
Book value: 44110117.056856185
P/B ratio: 1.1573293241299045
Market cap (USD): 51049931.960702345
Debt to equity: 0.6958462714523197
Current ratio: 0.899444888279903
Quick ratio: 0.5135453066507574
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCAL.NS — quarterly report dated 2024-12-31
Total revenue: 23697855.227882035
Gross profit: 11503380.34735983
Operating income: -107168.66767688541
Net income: 737148.8518475347
Capital expenditures: 0
Depreciation & amortization: 1233733.5353770836
Owner earnings: 1970882.3872246183
Buffett classification: The Gruesome
Stock price: 2.311924466721063
P/E ratio: 17.338774440623023
Shares outstanding: 22113625
Market cap (USD): 51125030.68539457
Effective tax rate (%): 18.882518182168006
Interest coverage ratio: -0.13694998063574343
COGS to revenue (%): 51.458137300858475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UCAL.NS — annual report dated 2025-03-31
Total revenue: 93791758.24175824
Gross profit: 45771790.97498246
Operating income: -133434.65045592704
Net income: -1903203.1797989244
Capital expenditures: 1152349.7778816926
Operating cash flow: 1707972.878185644
Depreciation & amortization: 4782768.295534252
Net tangible assets: 39536859.94856207
Owner earnings: 1727215.3378536352
Buffett classification: The Gruesome
Stock price: 1.527599486521181
Shares outstanding: 22113625
Book value: 41467149.871405184
P/B ratio: 0.8146391131264222
Market cap (USD): 33780762.19512195
Debt to equity: 0.8794674522849653
Current ratio: 0.9176313251696719
Quick ratio: 0.5189644401584211
Interest coverage ratio: -0.03869677244372118
COGS to revenue (%): 51.19849352114627
SG&A to revenue (%): 3.2229802839280874
Free cash flow (dilution-adjusted): 555623.1003039513
Buyback yield (%): 0
Retained earnings: 14835889.64227262
Inventory turnover: 3.124574401728256
Receivables turnover: 7.2564680493511835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.22264676955415638
FCF margin (%): 0.5924007724343685
Revenue growth (%): 8.800665935980437
Rule of 40 score: 9.393066708414805
Financial ratios for UCAL.NS — quarterly report dated 2025-03-31
Total revenue: 23251812.017769463
Gross profit: 10977975.216273088
Operating income: -1630348.375029226
Net income: -2405646.481178396
Capital expenditures: 0
Depreciation & amortization: 1208393.7339256487
Net tangible assets: 39536859.94856207
Owner earnings: -1197252.7472527472
Return on net tangible assets (%): -3.028193814102555
Buffett classification: The Gruesome
Stock price: 1.527599486521181
Shares outstanding: 22113625
Book value: 41467149.871405184
P/B ratio: 0.8146391131264222
Market cap (USD): 33780762.19512195
Debt to equity: 0.8794674522849653
Current ratio: 0.9176313251696719
Quick ratio: 0.5189644401584211
Interest coverage ratio: -2.293825454784697
COGS to revenue (%): 52.78658193226611
Buyback yield (%): 0
Retained earnings: 14835889.64227262
Inventory turnover: 0.7986368684486772
Receivables turnover: 1.798943043178215
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.720371340636293
Revenue growth (%): -1.8822091949813817
Rule of 40 score: -1.8822091949813817
Financial ratios for UCAL.NS — quarterly report dated 2025-06-30
Total revenue: 22761841.797332086
Gross profit: 11386601.919026446
Operating income: 73227.2408144161
Net income: -703241.2824713317
Capital expenditures: 0
Depreciation & amortization: 1121635.8530306576
Owner earnings: 418394.570559326
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8208518605195416
Shares outstanding: 22113625
Market cap (USD): 40265635.22408145
Interest coverage ratio: 0.07558336151504903
COGS to revenue (%): 49.97504147330877
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.107234567623949
Rule of 40 score: -2.107234567623949
Financial ratios for UCAL.NS — quarterly report dated 2025-09-30
Total revenue: 23822085.68207441
Gross profit: 11721657.271702368
Operating income: 644915.4453213078
Net income: -503866.9673055242
Capital expenditures: 0
Depreciation & amortization: 1042908.6809470124
Net tangible assets: 37365975.19729425
Owner earnings: 539041.7136414882
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5363021420518603
Shares outstanding: 22113625
Book value: 38985084.55467869
P/B ratio: 0.8714412151237558
Market cap (USD): 33973209.45603157
Debt to equity: 0.8715352936124212
Current ratio: 0.8809272075835501
Quick ratio: 0.5120752321103258
Interest coverage ratio: 0.7597619933060618
COGS to revenue (%): 50.79499995030806
Buyback yield (%): 0
Inventory turnover: 0.7838324175422914
Receivables turnover: 1.7389728877389115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.158371759089292
Revenue growth (%): 4.657988110903198
Rule of 40 score: 4.657988110903198
Financial ratios for UCAL.NS — quarterly report dated 2025-12-31
Total revenue: 22114548.290074635
Gross profit: 10112442.909658015
Operating income: -144703.13022167762
Net income: -1079324.9415172108
Capital expenditures: 0
Depreciation & amortization: 961969.4775537485
Owner earnings: -117355.46396346227
Buffett classification: The Gruesome
Stock price: 1.2299209089896401
Shares outstanding: 22113625
Market cap (USD): 27198009.761056032
Interest coverage ratio: -0.15874567696049077
COGS to revenue (%): 54.272441937253404
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -7.167875285095871
Rule of 40 score: -7.167875285095871
Financial ratios for VPT.V — annual report dated 2021-12-31
Capital expenditures: 3351.968503937008
Depreciation & amortization: 29233.07086614173
Buffett classification: The Gruesome
Stock price: 0.2755905511811023
Shares outstanding: 187659191
Market cap (USD): 51717099.88188975
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VPT.V — annual report dated 2022-12-31
Total revenue: 50122.794117647056
Gross profit: 42505.882352941175
Operating income: -3531497.7941176468
Net income: -3582941.176470588
Capital expenditures: 0
Operating cash flow: -3041722.058823529
Depreciation & amortization: 37429.41176470588
Net tangible assets: 3348173.5294117643
Owner earnings: -3545511.764705882
Return on net tangible assets (%): -105.89390703798998
Buffett classification: The Gruesome
Stock price: 0.19852941176470587
Shares outstanding: 187659191
Book value: 3348173.5294117643
P/B ratio: 11.127221595356206
Market cap (USD): 37255868.801470585
Debt to equity: 0.10081835662815285
Current ratio: 5.364381462242884
Quick ratio: 5.364381462242884
Interest coverage ratio: -170.54317875150912
COGS to revenue (%): 15.196502706588234
R&D to revenue (%): 1540.9127583728198
SG&A to revenue (%): 5747.85306673317
Free cash flow (dilution-adjusted): -3628525.7352941176
Buyback yield (%): 0
Retained earnings: -35750744.11764706
Receivables turnover: 0.18217800084451785
Capitalized R&D asset: 772348.5294117647
ROCI (R&D-adjusted, %): -68.70434795326436
FCF margin (%): -7239.2726685933085
Rule of 40 score: -7239.2726685933085
Financial ratios for VPT.V — annual report dated 2023-12-31
Total revenue: 37259.84848484848
Gross profit: 32146.969696969696
Operating income: -3686290.9090909087
Net income: -3690861.3636363633
Capital expenditures: 0
Operating cash flow: -2881737.8787878784
Depreciation & amortization: 50505.303030303025
Net tangible assets: 143716.66666666666
Owner earnings: -3640356.06060606
Return on net tangible assets (%): -2533.0089717773817
Buffett classification: The Gruesome
Stock price: 0.22727272727272727
Shares outstanding: 187659191
Book value: 143716.66666666674
P/B ratio: 296.76318777476706
Market cap (USD): 42649816.13636363
Debt to equity: 2.1740798920434767
Current ratio: 1.1719017708258006
Quick ratio: 1.1719017708258006
Interest coverage ratio: -83.2774944377888
COGS to revenue (%): 13.72222109265397
R&D to revenue (%): 2203.3141532643394
SG&A to revenue (%): 7907.76487810829
Free cash flow (dilution-adjusted): -3255451.5151515147
Buyback yield (%): 0
Retained earnings: -40524961.36363636
Receivables turnover: 0.17227030567532634
Capitalized R&D asset: 1338425.0298573975
ROCI (R&D-adjusted, %): -198.95598104722833
Rosenberg metric: -0.01341222551930153
FCF margin (%): -8737.15714779497
Revenue growth (%): -25.662866285161535
Rule of 40 score: -8762.820014080131
Financial ratios for VPT.V — quarterly report dated 2024-09-30
Gross profit: 47782.962962962956
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.1259259259259259
Shares outstanding: 187659191
Market cap (USD): 23631157.385185182
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VPT.V — annual report dated 2024-12-31
Total revenue: 66553.84615384616
Gross profit: 66553.84615384616
Operating income: -3357913.286713287
Net income: -3440260.839160839
Capital expenditures: 0
Operating cash flow: -2367971.3286713287
Depreciation & amortization: 43965.73426573427
Net tangible assets: -2085224.4755244756
Owner earnings: -3396295.1048951047
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 187659191
Book value: -2085224.4755244756
Market cap (USD): 13123020.349650351
Debt to equity: -0.5482601360018593
Current ratio: 0.13837998982931277
Quick ratio: 0.13837998982931277
Interest coverage ratio: -26.718912061252198
COGS to revenue (%): 0
R&D to revenue (%): 1018.4119278779473
SG&A to revenue (%): 4126.996385491531
Free cash flow (dilution-adjusted): -2846616.7832167833
Buyback yield (%): 0
Retained earnings: -40847917.48251748
Receivables turnover: 0.3788950685356891
Capitalized R&D asset: 1482704.8375497053
Rosenberg metric: 0.04191097259930912
FCF margin (%): -4277.163451435296
Revenue growth (%): 78.62081801247776
Rule of 40 score: -4198.542633422819
Financial ratios for VPT.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -735289.5104895105
Net income: -740989.5104895105
Capital expenditures: 0
Operating cash flow: -504065.73426573427
Depreciation & amortization: 10795.104895104896
Net tangible assets: -2085224.4755244756
Owner earnings: -730194.4055944056
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 187659191
Book value: -2085224.4755244756
Market cap (USD): 13123020.349650351
Debt to equity: -0.5482601360018593
Current ratio: 0.13837998982931277
Quick ratio: 0.13837998982931277
Free cash flow (dilution-adjusted): -526800
Buyback yield (%): 0
Retained earnings: -40847917.48251748
Receivables turnover: 0
Capitalized R&D asset: 134139.16083916085
Rule of 40 score: 0
Financial ratios for VPT.V — quarterly report dated 2025-03-31
Total revenue: 3009.7902097902097
Operating income: -591990.9090909091
Net income: -671174.8251748251
Capital expenditures: 0
Operating cash flow: -218546.85314685316
Depreciation & amortization: 10560.139860139861
Net tangible assets: -2471388.8111888114
Owner earnings: -660614.6853146853
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 187659191
Book value: -2471388.8111888114
Market cap (USD): 22309134.594405595
Debt to equity: -0.6021353187217289
Current ratio: 0.16966011398071773
Quick ratio: 0.16966011398071773
Interest coverage ratio: -7.702253682591961
COGS to revenue (%): 0
R&D to revenue (%): 2479.7165427509294
SG&A to revenue (%): 18846.189591078066
Free cash flow (dilution-adjusted): -317734.9650349651
Buyback yield (%): 0
Retained earnings: -41519092.30769231
Receivables turnover: 0.016746560418352735
Capitalized R&D asset: 164507.50349650352
FCF margin (%): -10556.71468401487
Rule of 40 score: -10556.71468401487
Financial ratios for VPT.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -852841.605839416
Net income: -940603.6496350365
Capital expenditures: 0
Operating cash flow: -399511.67883211677
Depreciation & amortization: 11144.525547445255
Net tangible assets: -2956462.04379562
Owner earnings: -929459.1240875912
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 187659191
Book value: -2956462.04379562
Market cap (USD): 17807076.518248174
Debt to equity: -0.5474614187948557
Current ratio: 0.08460999131125277
Quick ratio: 0.08460999131125277
Interest coverage ratio: -9.592953849437999
Free cash flow (dilution-adjusted): -658340.8759124087
Buyback yield (%): 0
Retained earnings: -44278050.3649635
Receivables turnover: 0
Capitalized R&D asset: 151612.4869582972
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for VPT.V — quarterly report dated 2025-09-30
Total revenue: 3096.402877697842
Operating income: -464718.70503597124
Net income: -541067.6258992807
Capital expenditures: 0
Operating cash flow: -68846.04316546764
Depreciation & amortization: 11105.755395683454
Net tangible assets: -3350696.402877698
Owner earnings: -529961.8705035972
Buffett classification: The Gruesome
Stock price: 0.07194244604316548
Shares outstanding: 187659191
Book value: -3350696.402877698
Market cap (USD): 13500661.223021585
Debt to equity: -0.5042666959815933
Current ratio: 0.04887881701325067
Quick ratio: 0.04887881701325067
Interest coverage ratio: -5.379181413165674
COGS to revenue (%): 0
R&D to revenue (%): 2297.9089219330854
SG&A to revenue (%): 15133.852230483271
Free cash flow (dilution-adjusted): -91066.18705035973
Buyback yield (%): 0
Retained earnings: -44182023.741007194
Receivables turnover: 0.03457611323998426
Capitalized R&D asset: 134200.70159032795
FCF margin (%): -2941.0315985130114
Rule of 40 score: -2941.0315985130114
Financial ratios for VRSN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 250.03
Shares outstanding: 90400000
Market cap (USD): 22602712000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRSN — annual report dated 2022-12-31
Total revenue: 1424900000
Gross profit: 1224200000
Operating income: 943100000
Net income: 673800000
Capital expenditures: 27400000
Operating cash flow: 831100000
Depreciation & amortization: 46900000
Net tangible assets: -1759700000
Owner earnings: 693300000
Return on net tangible assets (%): -39.39876115246917
Capex to operating income (%): 2.9053122680521684
Buffett classification: The Great
Stock price: 202.37
P/E ratio: 27.150857821311963
Shares outstanding: 90400000
Book value: -1562200000
Market cap (USD): 18294248000
Debt to equity: -1.149020611957496
Current ratio: 0.9299847792998478
Quick ratio: 0.9299847792998478
Effective tax rate (%): 23.449216087252896
Interest coverage ratio: 12.52456839309429
COGS to revenue (%): 14.085198961330619
R&D to revenue (%): 6.0144571548880625
SG&A to revenue (%): 13.713243034598918
Free cash flow (dilution-adjusted): 745100000
Buyback yield (%): 5.729123164833012
Retained earnings: -14204000000
Receivables turnover: 175.91358024691357
Capitalized R&D asset: 85700000
ROCI (R&D-adjusted, %): 142.44279882274756
FCF margin (%): 52.29138886939434
Rule of 40 score: 52.29138886939434
Financial ratios for VRSN — annual report dated 2023-12-31
Total revenue: 1493100000
Gross profit: 1295800000
Operating income: 1000600000
Net income: 817600000
Capital expenditures: 45800000
Operating cash flow: 853800000
Depreciation & amortization: 44100000
Net tangible assets: -1778500000
Owner earnings: 815900000
Return on net tangible assets (%): -45.875737981445035
Capex to operating income (%): 4.577253647811314
Buffett classification: The Great
Stock price: 202.88
P/E ratio: 22.431937377690804
Shares outstanding: 90400000
Book value: -1581000000
Market cap (USD): 18340352000
Debt to equity: -1.1369386464263125
Current ratio: 0.8315523769457299
Quick ratio: 0.8315523769457299
Effective tax rate (%): 16.272401433691755
Interest coverage ratio: 13.288180610889775
COGS to revenue (%): 13.214118277409417
R&D to revenue (%): 6.094702297233943
SG&A to revenue (%): 13.67624405599089
Free cash flow (dilution-adjusted): 748300000
Buyback yield (%): 4.914845691075068
Retained earnings: -13386400000
Receivables turnover: 109.78676470588235
Capitalized R&D asset: 148419000
ROCI (R&D-adjusted, %): 145.67249572941336
Rosenberg metric: 0.8354725787631272
FCF margin (%): 50.11720581340835
Revenue growth (%): 4.786300793038108
Rule of 40 score: 54.903506606446456
Financial ratios for VRSN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 187.12
Shares outstanding: 90400000
Market cap (USD): 16915648000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRSN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 203.87
Shares outstanding: 90400000
Market cap (USD): 18429848000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRSN — annual report dated 2024-12-31
Total revenue: 1557400000
Gross profit: 1366000000
Operating income: 1058200000
Net income: 785700000
Capital expenditures: 28100000
Operating cash flow: 902600000
Depreciation & amortization: 36900000
Net tangible assets: -2155400000
Owner earnings: 794500000
Return on net tangible assets (%): -36.86090748816925
Capex to operating income (%): 2.6554526554526556
Buffett classification: The Great
Stock price: 203.87
P/E ratio: 23.456596665393914
Shares outstanding: 90400000
Book value: -1957900000
Market cap (USD): 18429848000
Debt to equity: -0.9201184943051228
Current ratio: 0.4335445104826595
Quick ratio: 0.4335445104826595
Effective tax rate (%): 23.1138076132694
Interest coverage ratio: 14.053120849933599
COGS to revenue (%): 12.289713625272892
R&D to revenue (%): 6.209066392705791
SG&A to revenue (%): 13.554642352639013
Free cash flow (dilution-adjusted): 813400000
Buyback yield (%): 6.650081975716783
Retained earnings: -12600700000
Receivables turnover: 199.66666666666666
Capitalized R&D asset: 185951000
ROCI (R&D-adjusted, %): 1733.902734538421
Rosenberg metric: 0.7714285714285715
FCF margin (%): 52.228072428406314
Revenue growth (%): 4.306476458375193
Rule of 40 score: 56.53454888678151
Financial ratios for VRSN — quarterly report dated 2025-03-31
Total revenue: 402300000
Gross profit: 352900000
Operating income: 271200000
Net income: 199300000
Capital expenditures: 5800000
Operating cash flow: 291300000
Depreciation & amortization: 8900000
Net tangible assets: -2174500000
Owner earnings: 202400000
Return on net tangible assets (%): -9.307886870544953
Capex to operating income (%): 2.1386430678466075
Buffett classification: The Great
Stock price: 250.08
P/E ratio: 28.35829402910186
Shares outstanding: 90400000
Book value: -1977000000
Market cap (USD): 22607232000
Debt to equity: -0.906272129489125
Current ratio: 0.555028757966734
Quick ratio: 0.555028757966734
Effective tax rate (%): 22.871517027863778
Interest coverage ratio: 13.35960591133005
COGS to revenue (%): 12.27939348744718
R&D to revenue (%): 6.462838677603779
SG&A to revenue (%): 13.845389013174248
Free cash flow (dilution-adjusted): 268000000
Buyback yield (%): 1.0691269059387722
Retained earnings: -12401400000
Capitalized R&D asset: 26000000
ROCI (R&D-adjusted, %): 154.21343310172813
FCF margin (%): 66.61695252299279
Rule of 40 score: 66.61695252299279
Financial ratios for VRSN — quarterly report dated 2025-06-30
Total revenue: 409900000
Gross profit: 360800000
Operating income: 280700000
Net income: 207400000
Capital expenditures: 7800000
Operating cash flow: 202500000
Depreciation & amortization: 8300000
Net tangible assets: -2191300000
Owner earnings: 207900000
Return on net tangible assets (%): -9.487518824442112
Capex to operating income (%): 2.778767367296046
Buffett classification: The Great
Stock price: 285.26
P/E ratio: 63.40669781165479
Shares outstanding: 90400000
Book value: -1993800000
Market cap (USD): 25787504000
Debt to equity: -0.898585615407764
Current ratio: 0.5416798983804383
Quick ratio: 0.5416798983804383
Effective tax rate (%): 22.40927796483352
Interest coverage ratio: 14.851851851851851
COGS to revenue (%): 11.97853134910954
R&D to revenue (%): 6.269821907782386
SG&A to revenue (%): 13.271529641375945
Free cash flow (dilution-adjusted): 178800000
Buyback yield (%): 0.6468249117867321
Retained earnings: -12194000000
Receivables turnover: 14.744604316546763
Capitalized R&D asset: 43120000
ROCI (R&D-adjusted, %): 151.14293679002023
Rosenberg metric: 0.3038461538461538
FCF margin (%): 43.620395218345934
Revenue growth (%): 1.8891374596072583
Rule of 40 score: 45.50953267795319
Financial ratios for VRSN — quarterly report dated 2025-09-30
Total revenue: 419100000
Gross profit: 370300000
Operating income: 284300000
Net income: 212800000
Capital expenditures: 4700000
Operating cash flow: 307700000
Depreciation & amortization: 7300000
Net tangible assets: -2248000000
Owner earnings: 215400000
Return on net tangible assets (%): -9.58185053380783
Capex to operating income (%): 1.6531832571227576
Buffett classification: The Great
Stock price: 276.94
P/E ratio: 40.41222921711057
Shares outstanding: 90400000
Book value: -2050500000
Market cap (USD): 25035376000
Debt to equity: -0.8747134845159718
Current ratio: 0.5266620763522302
Quick ratio: 0.5266620763522302
Effective tax rate (%): 21.678321678321677
Interest coverage ratio: 15.042328042328043
COGS to revenue (%): 11.643999045573848
R&D to revenue (%): 6.0606060606060606
SG&A to revenue (%): 14.459556191839656
Free cash flow (dilution-adjusted): 284600000
Buyback yield (%): 0.8735638721783129
Retained earnings: -11981200000
Receivables turnover: 37.419642857142854
Capitalized R&D asset: 51199000
ROCI (R&D-adjusted, %): 192.15285624395293
Rosenberg metric: 0.36964980544747084
FCF margin (%): 67.90742066332618
Revenue growth (%): 2.244449865820932
Rule of 40 score: 70.1518705291471
Financial ratios for VRSN — quarterly report dated 2025-12-31
Total revenue: 425300000
Gross profit: 376300000
Operating income: 284800000
Net income: 206200000
Capital expenditures: 4500000
Operating cash flow: 289600000
Depreciation & amortization: 6700000
Net tangible assets: -2351900000
Owner earnings: 208400000
Return on net tangible assets (%): -8.860920957523705
Capex to operating income (%): 1.580056179775281
Buffett classification: The Great
Stock price: 241.41
P/E ratio: 26.430257962940534
Shares outstanding: 90400000
Book value: -2154200000
Market cap (USD): 21823464000
Debt to equity: -0.8346485934453626
Current ratio: 0.48946065561473256
Quick ratio: 0.48946065561473256
Effective tax rate (%): 23.93950571744744
Interest coverage ratio: 15.068783068783068
COGS to revenue (%): 11.521279097107923
R&D to revenue (%): 6.230895838231836
SG&A to revenue (%): 15.283329414530918
Free cash flow (dilution-adjusted): 267200000
Buyback yield (%): 1.1657177797255285
Retained earnings: -11775000000
Receivables turnover: 28.543624161073826
Capitalized R&D asset: 51999000
ROCI (R&D-adjusted, %): 637.1421981145412
Rosenberg metric: 0.23622047244094488
FCF margin (%): 62.82624030096402
Revenue growth (%): 1.4793605344786447
Rule of 40 score: 64.30560083544266
Financial ratios for VRSN — annual report dated 2025-12-31
Total revenue: 1656600000
Gross profit: 1460300000
Operating income: 1121000000
Net income: 825700000
Capital expenditures: 22800000
Operating cash flow: 1091100000
Depreciation & amortization: 31200000
Net tangible assets: -2351900000
Owner earnings: 834100000
Return on net tangible assets (%): -35.46494323738254
Capex to operating income (%): 2.0338983050847457
Buffett classification: The Great
Stock price: 241.41
P/E ratio: 26.430257962940534
Shares outstanding: 90400000
Book value: -2154200000
Market cap (USD): 21823464000
Debt to equity: -0.8346485934453626
Current ratio: 0.48946065561473256
Quick ratio: 0.48946065561473256
Effective tax rate (%): 22.72344408048666
Interest coverage ratio: 14.558441558441558
COGS to revenue (%): 11.8495714113244
R&D to revenue (%): 6.253772787637329
SG&A to revenue (%): 14.227936737896899
Free cash flow (dilution-adjusted): 998600000
Buyback yield (%): 4.039688658042555
Retained earnings: -11775000000
Receivables turnover: 111.18120805369128
Capitalized R&D asset: 198419000
ROCI (R&D-adjusted, %): 589.6380589794946
Rosenberg metric: 0.9751809720785936
FCF margin (%): 60.28009175419534
Revenue growth (%): 6.369590342879157
Rule of 40 score: 66.6496820970745
Financial ratios for XELB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 6056121
Market cap (USD): 66011718.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XELB — annual report dated 2022-12-31
Total revenue: 25781000
Gross profit: 17801000
Operating income: -22544000
Net income: -4018000
Capital expenditures: 265000
Operating cash flow: -14182000
Depreciation & amortization: 7263000
Net tangible assets: 23150000
Owner earnings: 2980000
Buffett classification: The Gruesome
Stock price: 7
Shares outstanding: 6056121
Book value: 70139000
P/B ratio: 0.604411910634597
Market cap (USD): 42392847
Debt to equity: 0.10286716377479006
Current ratio: 2.1368693796677336
Quick ratio: 1.7032464563328762
Interest coverage ratio: -18.739817123857023
COGS to revenue (%): 30.953027423296227
SG&A to revenue (%): 128.3193049144719
Free cash flow (dilution-adjusted): -15067000
Buyback yield (%): 1.0426287246053563
Retained earnings: -32797000
Inventory turnover: 2.804920913884007
Receivables turnover: 5.045205479452055
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.367858790395026
FCF margin (%): -58.44226368255691
Rule of 40 score: -58.44226368255691
Financial ratios for XELB — annual report dated 2023-12-31
Total revenue: 17755000
Gross profit: 10837000
Operating income: -19288000
Net income: -21052000
Capital expenditures: 100000
Operating cash flow: -6545000
Depreciation & amortization: 6954000
Net tangible assets: 8512000
Owner earnings: -14198000
Return on net tangible assets (%): -166.7998120300752
Buffett classification: The Gruesome
Stock price: 12.9
Shares outstanding: 6056121
Book value: 48171000
P/B ratio: 1.6218048390110233
Market cap (USD): 78123960.9
Debt to equity: 0.2075937804903365
Current ratio: 1.1289225537177308
Quick ratio: 1.0588962745401145
Interest coverage ratio: -50.6246719160105
COGS to revenue (%): 38.96367220501267
SG&A to revenue (%): 130.5040833568009
Free cash flow (dilution-adjusted): -6887000
Buyback yield (%): 0
Retained earnings: -53849000
Inventory turnover: 15.271523178807946
Receivables turnover: 5.140416907932831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.58690616802933
FCF margin (%): -38.78907350042242
Revenue growth (%): -31.131453395911716
Rule of 40 score: -69.92052689633414
Financial ratios for XELB — quarterly report dated 2024-09-30
Gross profit: 1505000
Capital expenditures: 8000
Buffett classification: The Gruesome
Stock price: 7.48
Shares outstanding: 6056121
Market cap (USD): 45299785.080000006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XELB — quarterly report dated 2024-12-31
Gross profit: 1209000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.15
Shares outstanding: 6056121
Market cap (USD): 31189023.150000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XELB — annual report dated 2024-12-31
Total revenue: 8259000
Gross profit: 7814000
Operating income: -9891000
Net income: -22395000
Capital expenditures: 112000
Operating cash flow: -4716000
Depreciation & amortization: 4947000
Net tangible assets: -4335000
Owner earnings: -17560000
Buffett classification: The Gruesome
Stock price: 5.15
Shares outstanding: 6056121
Book value: 28398000
P/B ratio: 1.0982823843228398
Market cap (USD): 31189023.150000002
Debt to equity: 0.47112472709345726
Current ratio: 0.388974408312488
Quick ratio: 0.388974408312488
Interest coverage ratio: -15.358695652173912
COGS to revenue (%): 5.3880615086572226
SG&A to revenue (%): 154.47390725269403
Free cash flow (dilution-adjusted): -5231000
Buyback yield (%): 0.34306941735685614
Retained earnings: -76244000
Receivables turnover: 3.639929484354341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.81029472810295
FCF margin (%): -63.3369657343504
Revenue growth (%): -53.48352576738947
Rule of 40 score: -116.82049150173987
Financial ratios for XELB — quarterly report dated 2025-03-31
Total revenue: 1332000
Operating income: -1851000
Net income: -2797000
Capital expenditures: 14000
Operating cash flow: -1434000
Depreciation & amortization: 900000
Net tangible assets: -6141000
Owner earnings: -1911000
Buffett classification: The Gruesome
Stock price: 2.82
Shares outstanding: 6056121
Book value: 25710000
P/B ratio: 0.6642653138856476
Market cap (USD): 17078261.22
Debt to equity: 0.5939323220536756
Current ratio: 0.2778997613365155
Quick ratio: 0.2778997613365155
Interest coverage ratio: -3.305357142857143
COGS to revenue (%): 0
SG&A to revenue (%): 171.3963963963964
Free cash flow (dilution-adjusted): -1557000
Buyback yield (%): 0.33961302765457996
Retained earnings: -79041000
Receivables turnover: 0.6327790973871734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.40598890766704
FCF margin (%): -116.89189189189189
Rule of 40 score: -116.89189189189189
Financial ratios for XELB — quarterly report dated 2025-06-30
Total revenue: 1321000
Gross profit: 1321000
Operating income: -1474000
Net income: -3988000
Capital expenditures: 4000
Operating cash flow: -2364000
Depreciation & amortization: 899000
Net tangible assets: -8469000
Owner earnings: -3093000
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 6056121
Book value: 22496000
P/B ratio: 0.4872679147403983
Market cap (USD): 10961579.01
Debt to equity: 0.8185899715504978
Current ratio: 0.5870837907061837
Quick ratio: 0.5870837907061837
Interest coverage ratio: -3.026694045174538
COGS to revenue (%): 0
SG&A to revenue (%): 143.52763058289176
Free cash flow (dilution-adjusted): -2489000
Buyback yield (%): 0.5291208497159754
Retained earnings: -83029000
Receivables turnover: 0.7246297312122875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.532823622462431
FCF margin (%): -188.41786525359575
Revenue growth (%): -0.8258258258258258
Rule of 40 score: -189.24369107942158